With the in-depth research in the field of tumor immunotherapeutics, tumor immune microenvironment has captured great attention in lung cancer treatment, and the superior efficacy of immune sentinel inhibitors represented by PD-1 and its ligand PD-L1 inhibitors has deepened the study of tumor immune microenvironment. The gene discussed is CD274; the disease is neoplasm.